The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids, which are often available as generics for $1 or less. Vertex began researching ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive risks of opioids.

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new ... said in a statement. “A new non-opioid analgesic therapeutic class for acute pain offers an opportunity ...

offers a non-opioid alternative for pain management. While the company asserts that the cost is in line with other brand-name pain medications, some experts, as reported by USA TODAY, have raised ...

The medication will be sold under the brand name Journavx ... the drug’s development and review underscore FDA’s commitment to approving safe and effective alternatives to opioids for pain ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...